To assess degree of cyclooxygenase-2 (COX-2) selectivity of a non-steroidal anti-inflammatory drug (NSAID) and risk of myocardial infarction (MI) or cerebrovascular accident (CVA).
Houston Center for Quality of Care and Utilization Studies, and Deparment of Gastroenterology, Michael E. DeBakey VAMC and Baylor College of Medicine, Houston, TX 77030, USA. nabraham@bcm.tmc.edu
